Hypertension Program, Hospital de Clinicas J. de San Martin, University of Buenos Aires School of Medicine, Buenos Aires, Argentina.
Curr Hypertens Rep. 2010 Dec;12(6):465-73. doi: 10.1007/s11906-010-0153-z.
Most current guidelines recommend tighter blood pressure (BP) control in hypertensive patients with comorbidities. These recommendations are based on epidemiologic data indicating that cardiovascular risk increases at lower BP levels in hypertensive patients with comorbidities than in those without comorbidities. Hypertension guidelines usually reflect outcomes from previous studies, but current recommendations for patients with comorbidities have preceded the evidence. We review recent studies investigating whether these new targets can be achieved, whether they are well tolerated, and whether they positively affect the outcomes. The results of the few current studies about outcomes in lower BP target groups are either negative or somewhat--but not decidedly--positive. There is a need for new trials designed to evaluate the validity of current recommendations for tighter BP control in hypertensive patients with comorbidities. Additionally, existing data from published trials could be reanalyzed to provide further clarification.
大多数现行指南建议合并症高血压患者应更严格地控制血压(BP)。这些建议基于流行病学数据,表明与无合并症的高血压患者相比,合并症高血压患者的心血管风险在较低的 BP 水平下会增加。高血压指南通常反映了以往研究的结果,但目前针对合并症患者的建议先于证据提出。我们回顾了最近的研究,以探讨这些新目标是否可以实现,是否能够良好耐受,以及是否对结果产生积极影响。关于较低 BP 目标组的结果的少数现有研究结果要么是负面的,要么是有些——但不是明确的——正面的。需要进行新的试验来评估当前建议在合并症高血压患者中更严格控制血压的有效性。此外,可重新分析已发表试验的现有数据以提供进一步澄清。